• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种异常的纤维蛋白原福冈II(甘氨酸-Bβ15→半胱氨酸),其特征为纤维蛋白侧向缔合缺陷和混合二硫键形成。

An abnormal fibrinogen Fukuoka II (Gly-B beta 15-->Cys) characterized by defective fibrin lateral association and mixed disulfide formation.

作者信息

Kamura T, Tsuda H, Yae Y, Hattori S, Ohga S, Shibata Y, Kawabata S, Hamasaki N

机构信息

Department of Clinical Chemistry and Laboratory Medicine, Kyushu University Faculty of Science, Fukuoka, Japan.

出版信息

J Biol Chem. 1995 Dec 8;270(49):29392-9. doi: 10.1074/jbc.270.49.29392.

DOI:10.1074/jbc.270.49.29392
PMID:7493975
Abstract

A dysfibrinogenemia was attributable to a single amino acid substitution from glycine to cysteine at residue 15 of the B beta chain in a fibrinogen molecule designated as fibrinogen Fukuoka II. The fibrinogen Fukuoka II showed prolonged thrombin and reptilase times and impaired fibrinopeptide B release by thrombin, resulting in abolition of fibrin monomer repolymerization under physiological conditions. Repolymerization of the des-(B beta 1-42)-fibrin monomers, however, was not distinguished from the normal pattern of des-(B beta 1-42)-fibrin monomers, suggesting that no other abnormality existed in fibrinogen Fukuoka II. Although an additional cysteine was substituted at residue 15 of the B beta chain, fibrinogen Fukuoka II had no free sulfhydryl group within the molecule. Instead, fibrinogen Fukuoka II formed a disulfide bond with cysteine, albumin, another mutated B beta chain within the same molecule, or intermolecular dimeric fibrinogen Fukuoka II. The mutation in fibrinogen Fukuoka II was the same as that in fibrinogen Ise published previously (Yoshida, N., Wada, H., Morita, K., Hirata, H., Matsuda, M., Yamazumi, K., Asakura, S., and Shirakawa, S. (1991) Blood 77, 1958-1963). Fibrinogen Ise, however, has been described as having prolonged thrombin time but normal reptilase time. Reasons for the discrepancy were not clear. Analysis of the B beta 1-42 fragment showed that fibrinogen was heterogeneous at position 31 of the B beta chain with respect to proline or hydroxyproline.

摘要

一种异常纤维蛋白原血症归因于在名为纤维蛋白原福冈II的纤维蛋白原分子Bβ链第15位残基处,甘氨酸被半胱氨酸单氨基酸取代。纤维蛋白原福冈II表现出凝血酶和蛇毒凝血酶时间延长,以及凝血酶介导的纤维蛋白肽B释放受损,导致在生理条件下纤维蛋白单体再聚合被抑制。然而,去(Bβ1 - 42)-纤维蛋白单体的再聚合与正常去(Bβ1 - 42)-纤维蛋白单体模式并无差异,这表明纤维蛋白原福冈II不存在其他异常。尽管在Bβ链第15位残基处额外取代了一个半胱氨酸,但纤维蛋白原福冈II分子内没有游离巯基。相反,纤维蛋白原福冈II与半胱氨酸、白蛋白、同一分子内另一条突变的Bβ链或分子间二聚体纤维蛋白原福冈II形成二硫键。纤维蛋白原福冈II中的突变与先前发表的纤维蛋白原伊势中的突变相同(吉田,N.,和田,H.,森田,K.,平田,H.,松田,M.,山津,K.,朝仓,S.,和白川,S.(1991年)《血液》77,1958 - 1963)。然而,纤维蛋白原伊势被描述为凝血酶时间延长但蛇毒凝血酶时间正常。差异的原因尚不清楚。对Bβ1 - 42片段的分析表明,纤维蛋白原在Bβ链第31位脯氨酸或羟脯氨酸位置上是异质的。

相似文献

1
An abnormal fibrinogen Fukuoka II (Gly-B beta 15-->Cys) characterized by defective fibrin lateral association and mixed disulfide formation.一种异常的纤维蛋白原福冈II(甘氨酸-Bβ15→半胱氨酸),其特征为纤维蛋白侧向缔合缺陷和混合二硫键形成。
J Biol Chem. 1995 Dec 8;270(49):29392-9. doi: 10.1074/jbc.270.49.29392.
2
A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine.一种新的先天性异常纤维蛋白原的特征是β链甘氨酸-15被半胱氨酸取代。
Blood. 1991 May 1;77(9):1958-63.
3
Functional analysis of recombinant Bbeta15C and Bbeta15A fibrinogens demonstrates that Bbeta15G residue plays important roles in FPB release and in lateral aggregation of protofibrils.重组Bβ15C和Bβ15A纤维蛋白原的功能分析表明,Bβ15G残基在纤维蛋白原β链释放和原纤维横向聚集中起重要作用。
J Thromb Haemost. 2005 May;3(5):983-90. doi: 10.1111/j.1538-7836.2005.01294.x.
4
A new substitution, gamma 358 Ser-->Cys, in fibrinogen Milano VII causes defective fibrin polymerization.
Blood. 1994 Sep 15;84(6):1874-80.
5
Abnormal fibrinogens IJmuiden (B beta Arg14----Cys) and Nijmegen (B beta Arg44----Cys) form disulfide-linked fibrinogen-albumin complexes.异常纤维蛋白原艾默伊登型(Bβ链精氨酸14位至半胱氨酸)和奈梅亨型(Bβ链精氨酸44位至半胱氨酸)形成二硫键连接的纤维蛋白原 - 白蛋白复合物。
Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3478-82. doi: 10.1073/pnas.89.8.3478.
6
Fibrinogen Kyoto II, a new congenitally abnormal molecule, characterized by the replacement of A alpha proline-18 by leucine.纤维蛋白原京都II,一种新的先天性异常分子,其特征是αA链脯氨酸-18被亮氨酸取代。
Blood. 1991 Jul 1;78(1):149-53.
7
Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro).马格德堡纤维蛋白原I:一种新型人类纤维蛋白原变体,其纤维蛋白肽A存在氨基酸交换(Aα9,亮氨酸→脯氨酸)。
Thromb Res. 2003 Jan 25;109(2-3):145-51. doi: 10.1016/s0049-3848(03)00114-2.
8
Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".阿莱斯纤维蛋白原:一种异常纤维蛋白原血症(γ-天冬氨酸(330)→缬氨酸)的纯合病例,其特征为纤维蛋白聚合位点“a”存在缺陷。
Blood. 2000 Nov 15;96(10):3473-9.
9
Fibrinogen Bern I: substitution gamma 337 Asn-->Lys is responsible for defective fibrin monomer polymerization.纤维蛋白原伯尔尼I:γ337位天冬酰胺替换为赖氨酸导致纤维蛋白单体聚合缺陷。
Blood. 1993 Oct 1;82(7):2104-8.
10
Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.纤维蛋白原圣加仑I(γ292位甘氨酸突变为缬氨酸):结构改变导致聚合缺陷和纤维蛋白原溶解的证据
Thromb Haemost. 1999 Feb;81(2):268-74.

引用本文的文献

1
Increased thrombosis susceptibility and altered fibrin formation in STAT5-deficient mice.STAT5 缺陷小鼠血栓形成易感性增加和纤维蛋白形成改变。
Blood. 2010 Dec 16;116(25):5724-33. doi: 10.1182/blood-2010-06-292227. Epub 2010 Sep 7.
2
Polymerization of fibrin: Direct observation and quantification of individual B:b knob-hole interactions.纤维蛋白的聚合:单个Bβ链球-孔相互作用的直接观察与定量分析
Blood. 2007 Jan 1;109(1):130-8. doi: 10.1182/blood-2006-07-033910. Epub 2006 Aug 29.